Clinical Trial Update: Study to Evaluate Efficacy and Safety of Entelon 50mg in Patients With Non-Proliferative Diabetic Retinopathy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating efficacy and safety of Entelon 50mg in patients with non-proliferative diabetic retinopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-proliferative Diabetic Retinopathy

Drugs mentioned

• Entelon

Snippet

Sponsor: Hanlim Pharm. Co., Ltd. | Conditions: Non Proliferative Diabetic Retinopathy | Phase 4 | Status: UNKNOWN